CP
Therapeutic Areas
Amneal Pharmaceuticals Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Mesalamine DR (Asacol® HD) | Gastroenterology (Ulcerative Colitis) | ANDA Approved |
| Everolimus (Afinitor®) | Oncology | ANDA Approved |
| Epinephrine (Adrenalin®) | Emergency/Critical Care | ANDA Pending |
| Prednisolone acetate (Pred-Forte®) | Ophthalmology | ANDA Pending |
| Risperidone ER (Risperdal Consta®) | Psychiatry | ANDA Pending |
| Iohexol (Omnipaque®) | Diagnostic Imaging | ANDA Pending |
| Eltrombopag (Promacta®) | Hematology | ANDA Pending |
Leadership Team at Amneal Pharmaceuticals
CP
Chintu Patel
Co-Chief Executive Officer
TK
Tasos Konidaris
Executive Vice President, Chief Financial Officer
AS
Andrew S. Boyer
Executive Vice President, Chief Commercial Officer – Generics & Biosciences
JR
Joe Renda
Senior Vice President, Chief Commercial Officer - Specialty
SK
Srinivas Kone, PhD
Senior Vice President, Chief Scientific Officer – Generics
MW
Maryll W. Toufanian
Senior Vice President, Regulatory Strategy and Government Affairs
PM
Paul Meister
Chairman of the Board